Skip to main content

Faricimab Ophthalmic Dosage

Medically reviewed by Drugs.com. Last updated on Nov 15, 2023.

Applies to the following strengths: svoa 6 mg/0.05 mL

Usual Adult Dose for Macular Degeneration

6 mg intravitreally every 4 weeks for the first 4 doses, followed by 6 mg intravitreally on:


Comments:

Use: For the treatment of patients with neovascular (wet) age-related macular degeneration

Usual Adult Dose for Retinal Disorder

DIABETIC MACULAR EDEMA (DME):
Regimen 1: 6 mg intravitreally every 4 weeks for at least 4 doses

-OR-
Regimen 2: 6 mg intravitreally every 4 weeks for the first 6 doses, followed by 6 mg intravitreally every 8 weeks (2 months)

MACULAR EDEMA FOLLOWING RETINAL VEIN OCCLUSION (RVO): 6 mg intravitreally every 4 weeks for 6 months

Comments:

Use: For the treatment of patients with DME or macular edema following RVO

Usual Adult Dose for Macular Edema

DIABETIC MACULAR EDEMA (DME):
Regimen 1: 6 mg intravitreally every 4 weeks for at least 4 doses

-OR-
Regimen 2: 6 mg intravitreally every 4 weeks for the first 6 doses, followed by 6 mg intravitreally every 8 weeks (2 months)

MACULAR EDEMA FOLLOWING RETINAL VEIN OCCLUSION (RVO): 6 mg intravitreally every 4 weeks for 6 months

Comments:

Use: For the treatment of patients with DME or macular edema following RVO

Renal Dose Adjustments

Mild to severe renal dysfunction (CrCl 15 to 89 mL/min/1.73 m2 [estimated normalized CrCl by Cockcroft-Gault equation]): No adjustment recommended
CrCl less than 15 mL/min/1.73 m2: Data not available

Liver Dose Adjustments

Liver dysfunction: Data not available

Precautions

CONTRAINDICATIONS:


Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Injection Procedure:

Storage requirements:

Reconstitution/preparation techniques:

Monitoring:

Patient advice:

Does Faricimab ophthalmic interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.